Physicians' Academy for Cardiovascular Education

Why is early screening and risk identification of CKD in diabetes important?

Listen to the podcast
10' education - July 6, 2022 - Rikke Borg, MD, PhD - Roskilde, Denmark

Video navigation menu

  • Kidney disease - a continuum 00:23
  • Changing diabetic nephropathy 03:53
  • How are we doing with regard to UACR testing? 06:23
  • ADA guidelines and outcomes of large trials 08:06
  • DKD from 1976 up until now 11:28
  • Take home messages 13:26


Show transcript

Educational information

This lecture by Rikke Borg was part of the EBAC-accredited symposium "Rethinking the role of nephrologists in prevention of CKD - The opportunity of early risk identification" held during the ERA 2022 congress.


Rikke Borg is Clinical Research Associate Professor at the Department of Clinical Medicine at the University of Copenhagen, Denmark.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim and Lilly Alliance.

Click here for the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: